Pan-immune-inflammation value and survival in patients with breast cancer from a Peruvian reference hospital

Pan-immune-inflammation value and survival in patients with breast cancer from a Peruvian reference hospital

The pan-immune-inflammation value (PIV), calculated as (neutrophil × platelet × monocyte)/lymphocyte count, may be useful for estimating survival in breast cancer patients. To determine the prognostic value of PIV for overall survival in breast cancer patients in Lima, Peru. A retrospective cohort s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2024-07, Vol.14 (1), p.17132-9, Article 17132
Hauptverfasser: Palomino-Secca, Iris, Peña-Tuya, Mariella, Quintana-García, Lynn A., Guevara Pinares, Miguel A., Quiñones-Laveriano, Dante M., Malpartida Palomino, Robert, De La Cruz-Vargas, Jhony A.
Format: Artikel
Sprache:eng
Schlagworte:
631/67
692/4028
692/53
Adult
Aged
Biomarker
Breast cancer
Breast Neoplasms - immunology
Breast Neoplasms - mortality
Breast Neoplasms - pathology
Cell number
Female
Hemoglobin
Humanities and Social Sciences
Humans
Inflammation
Kaplan-Meier Estimate
Leukocytes (neutrophilic)
Lymphocytes
Medical records
Middle Aged
Monocytes
Monocytes - immunology
multidisciplinary
Neutrophils - immunology
Pan-immune-inflammation value
Patients
Peru - epidemiology
Prognosis
Proportional Hazards Models
Retrospective Studies
Science
Science (multidisciplinary)
Statistical analysis
Statistical models
Survival
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The pan-immune-inflammation value (PIV), calculated as (neutrophil × platelet × monocyte)/lymphocyte count, may be useful for estimating survival in breast cancer patients. To determine the prognostic value of PIV for overall survival in breast cancer patients in Lima, Peru. A retrospective cohort study was conducted. 97 breast cancer patients diagnosed between January 2010 and December 2016 had their medical records analyzed. The primary dependent variable was overall survival, and the key independent variable was the PIV, divided into high (≥ 310) and low (
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-024-68304-y